# Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer

> **NCT03348748** · EARLY_PHASE1 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 20 (actual)

## Conditions studied

- Stage I Non-Small Cell Lung Cancer AJCC v7
- Stage IA Non-Small Cell Lung Carcinoma AJCC v7
- Stage IB Non-Small Cell Lung Carcinoma AJCC v7
- Stage II Non-Small Cell Lung Cancer AJCC v7
- Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
- Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
- Stage IIIA Non-Small Cell Lung Cancer AJCC v7

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Quality-of-Life Assessment
- **DRUG:** Stereotactic Body Radiation Therapy
- **DRUG:** Stereotactic Body Radiation Therapy
- **DRUG:** Stereotactic Body Radiation Therapy
- **PROCEDURE:** Thoracic Surgical Procedure

## Key facts

- **NCT ID:** NCT03348748
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-18
- **Primary completion:** 2021-07-12
- **Final completion:** 2025-11-10
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03348748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03348748, "Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03348748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*